Mountain View, California-based IGM Biosciences Inc, a biotech firm focused on developing engineered IgM antibodies for therapeutic use, has raised about $175 million for its IPO of nearly 11 million shares at $16 per share. The stock began trading September 18, 2019 on the NASDAQ under the ticker symbol "IGMS." The lead underwriters are Jefferies, Piper Jaffray, Stifel and Guggenheim Securities. IGM's pre-IPO backers include Redmile Group, Janus Henderson Investors and Vivo Capital.
WeWork has opted to postpone its much anticipated IPO after struggling to raise investor interest, according to press reports. WeWork had expected to launch the roadshow for its IPO on Monday, and to price and list its shares next week, the Financial Times reported. WeWork now plans to complete the offering by year-end, the story said.
Endeavor, the talent agency backed by Silver Lake, is targeting an $8 billion valuation in an upcoming IPO, the Financial Times is reporting. Endeavor, which own William Morris Agency and IMG, could raise as much as $712 million, the story said.
Endeavor Group Holdings Inc, a Beverly Hills, California-based talent agency and events company, is looking to raise up to US$619 million from an initial public offering (IPO), according to a report by Reuters. The IPO, which will be launched on the New York Stock Exchange, could value Endeavour at as much as US$7.8 billion, the […]
Beverly Hills, California-based Endeavor Group, a global entertainment company, is seeking to raise up to $619 million for its IPO, reported Reuters. The company is planning on pricing its IPO of about 19.4 million shares between $30 and $32 per share. Goldman Sachs, KKR, J.P. Morgan and Morgan Stanley are serving as lead underwriters. Endeavor is backed by Silver Lake Partners and CPPIB.
Madewell Group, J Crew's denim brand, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. J Crew is backed by Leonard Green & Partners and TPG Capital.
Stamford, Connecticut-based SpringWorks Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, has raised $162 million for its IPO after pricing its 9 million shares at $18 per share. The stock began trading September 13, 2019 on the NASDAQ under the ticker symbol "SWTX." J.P. Morgan Securities LLC, Goldman Sachs and Cowen and Company LLC are the lead underwriters. SpringWorks' pre-IPO backers include Perceptive Advisors, Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc.
Satsuma Pharmaceuticals Inc, which is focused on treating migraines, has raised $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share. The stock began trading September 13, 2019 on the NASDAQ under the ticker symbol "STSA." Credit Suisse, SVB Leerink and Evercore ISI are the lead underwriters. Satsuma's pre-IPO backers include RA Capital Management and TPG Biotech.
New York-based Peloton Interactive, a fitness startup, is seeking to raise up to $1.33 billion for its IPO, reported Reuters. Goldman Sachs, J.P. Morgan, BOfA Merrill Lynch and Barclays are among the underwriters for the IPO. Peloton's backers include TCV, Felix Capital, Tiger Global, Kleiner Perkins, Wellington Management and NBCUniversal, according to Crunchbase.
Ping Identity, a security solutions provider, has priced its IPO of 12.5 million shares at between $14 and $16 per share. The stock will trade on the New York Stock Exchange under the ticker symbol "PING." Goldman Sachs, BofA Merrill Lynch, RBC Capital Markets and Citigroup will serve as lead underwriters. Ping Identity is backed by Vista Equity Partners.